International Journal of Pharmaceutical and Phytopharmacological Research (eIJPPR) publishes research papers, short communications, review articles and book reviews dealing with Pharmaceutics, Novel Drug Delivery, Pharmaceutical Technology, Biopharmaceutics, Pharmacokinetics, Nanotechnology, Pharmacognosy, Phytochemistry, Natural Product Research, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacology and Toxicology, Pharmaceutical Analysis, Quality Control, Quality Assurance, Drug Regulatory Affair, Pharmacy Practice, Clinical and Hospital Pharmacy, Pharmacogenomics, Bioinformatics, Pharmaceutical Biotechnology & Microbiology.
eIJPPR also publishes research work/papers related to Ayurvedic/herbal medicines & all forms of alternative medicines.
Manuscripts are accepted on the understanding that the authors have obtained the necessary authority for publication. Manuscripts with multi-authors imply the consent of each of the authors. The publisher will presume that the corresponding author has specifically obtained the approval of all other co-authors to submit the article to eIJPPR. Submission of an article to eIJPPR is understood to imply that it has not been either published or not being considered for publication elsewhere.
Manuscripts will be reviewed by members of the editorial board, whose opinions will form the basis of the final decision by the editor. It is recommended that an English check of the manuscript by a competent and knowledgeable native speaker be completed before submission. Failure to follow them may result in papers being delayed or rejected.
Research papers should contain unpublished results of original research, which must be presented in sufficient detail
to ensure the reproducibility of the described experiments and should present new experimental studies in elaborate form that constitute a significant contribution to knowledge. Research Papers should not exceed 18 pages.
Short communications are the one that should present new important findings in brief, a maximum of 9 pages
Review articles should bring up the most important current topics or present interpretative and critical accounts, but
not simple compilation, on subjects of general interest. They should be around 15 pages.
The Journal publishes reviews of books that are newly published. Book reviews are solicited at the discretion of the editor. Publishers submitting a book for review should send 2 copies of the book to the editor's address.
A case study should based on an in-depth investigation of a single individual, group, or event. Case studies may be
descriptive or explanatory. Case study should involve an in-depth, longitudinal (over a long period of time) examination of a single instance or event. They provide a systematic way of looking at events, collecting data, analyzing information, and reporting the results. Case studies are the critical surveys of any complication performed in any region, area or demography to study and focus the causes and exclusion of complication.
Each manuscript should be neatly typed, single-spaced throughout; including tables, graphs, figures etc. Manuscript
should be uniform size with at least 2.5cm margin on all sides. Prepare the manuscript in Times New Roman font using a font size of 12. Title shall be in a font size 14, bold face capitals. All section titles in the manuscript shall be in font size 12, bold face capitals. Subtitles in each section shall be in font size 12, bold face lower case. Standard International Units could be used throughout the text.
Pages should not be numbered; manuscript should be starting with the title page and the text should be arranged in the following order:
The title should be clear, concise and informative followed by the names and affiliations of the authors. Each author
must provide their full name including their forenames and surname. The affiliation should comprise the department, institution (usually university or company), city, and state (or nation) and should be typed as a footnote to the author’s name. The Corresponding Author of the manuscript must be marked with an asterik and should be listed first. In addition, the corresponding author must indicate his or her complete mailing address, office/cellular phone number, fax number and email address at the lower left of the title page.
The abstract with keywords should be typed on a separate sheet. The abstract should not more than 300 words and
should present the reason of study, the main findings and principal conclusion. Abstract should not be structured. Abstract must be followed by four-six keywords.
Should start on a new page and should clearly indicate the aim of the study. The introduction should not be an
extensive review of the literature but should refer only to previous work which has a direct bearing on the topic to be discussed.
The section Materials and Methods should include concise details on the methodology adopted, sufficient to repeat
the experiment. Please provide concise but complete information about the material and the analytical, statistical and experimental procedures used. Extracts and/or fractions tested for in vitro or in vivo biological activities should be chemically defined, at least by means of the results of preliminary phytochemical screening. Complete formulation details of all crude drug mixtures and extracts should be mentioned. The plant name should be fully mentioned when cited first, and the authors are asked to add the details regarding its identification, voucher herbarium specimen number and name of the herbarium institution where it has been deposited. The statistical method and the level of significance chosen should be clearly stated. In case of animal experiments authors must give the details of ethical approval.
Data acquired from the research with appropriate statistical analysis described in the methods section should be
included in this section. All results presented in tabular or graphical form shall be described in this section. Should contain a critical review of the results of the study with the support of relevant literature. Discussion should relate the results to current understanding of the scientific problems being investigated in the field.
In a separate section, the major findings of the study and their usefulness shall be summarized. This paragraph
should address the main conclusions of the work highlighting its importance and relevance.
All acknowledgments should be typed in one paragraph directly preceding the reference section and may include
supporting grants, presentations, and so forth.
The authors are responsible for the accuracy of the bibliographic information. The references should be listed on a
separate sheet and should be numbered consecutively in the order in which they are cited in the text. Cite in the text by the appropriate Arabic number e.g. 1, 2, 3 and the numbers should be superscripted. The commonly cited types of references are shown below, for other types of references such as electronic media, newspaper items, etc. please refer to ICMJE Guidelines (http://www.icmje.org).
Author (last name) AB (initials), Author BB. Title of Article, Journal name, year, volume (issue): page numbers. (If
author number is more than two use et al after the names of two authors)
Wright CI, Van-Buren L, et al "Herbal medicines as diuretics: a review of the scientific evidence" J Ethnopharmacol, 2007,114 (1): 1–31.
Author AB, Author BB, Author CC. Title of Book. Edition, Volume, Publisher, City, year, page numbers.
Parrot EL, Lachman L, Libermann HA and Kanig JL, Theory and Practice of Industrial Pharmacy, 3rd edition, Lea and Febiger, Philiadelphia, 1986, 21.
Each table should have a short, descriptive title and numbered in the order (using Arabic numerals) cited in the text.
Abbreviations should be defined as footnotes in italics at the bottom of each table. Please do not duplicate material that is already presented in the tables.
Table Format - Exactly same as below
Treatment and Dose
Number of writhes ( % Writhing)
% Writhing Inhibition
1% tween 80 solution
10 ml/kg, p.o.
29.6 ± 1.99
Diclofenac Na 25 mg/kg, p.o.
6.90 ± 1.25 *
Ethanol Extract of B. tersa
250 mg/kg, p.o.
Ethanol Extract of B. tersa
500 mg/kg, p.o.
Values are expressed as mean±SEM (Standard Error Mean); * indicates P < 0.001, one-way ANOVA followed by Dunnet’s test as compared to control; n = Number of mice; p.o.: per oral.
Figures (photographs, drawings, diagrams and charts) are to be numbered in one consecutive series of the Arabic
numerals in the order in which they are cited in the text and abbreviated as Fig.X. Photos or drawings must have a
good contrast of dark and light. Legends of figures should be brief, but complete and self- explanatory so that the reader can easily understand the results presented in the figure.
Standard abbreviations should be used throughout the manuscript. All nonstandard abbreviations should be kept to a
minimum and must be defined in the text following their first use.
The journal publishes exciting findings, preliminary data or studies that did not yield enough information to make a
full paper as short communications. These have the same format requirements as full papers but are only up to 9 pages in length. Short Communications should not have subtitles such as Introduction, Materials and Methods, Results and Discussion - all these have to be merged into the running text. Short Communications preferably should have only 3-4 illustrations.
Should be about 18 pages long, contain up-to-date information, comprehensively cover relevant literature and
preferably be written by scientists who have in-depth knowledge on the topic. All format requirements are same as those applicable to full papers. Review articles need not be divided into sections such as Materials and Methods and Results and Discussion, but should definitely have an Abstract and Introduction, if necessary.
Similar format as Research paper.
Authors publishing results from in vivo experiments involving animals or humans should state whether due permission for conduction of these experiments was obtained, from the relevant ethics committees, in the Materials and Methods section. In addition, authors wishing to publish research work involving human studies should also send a notary verified letter of approval from the Ethics Committee or the Institutional Review Board.
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.
Plagiarism is a serious issue around the world in the arena of manuscript writing. Plagiarism means "Use or close
imitation of the language and thoughts of another author and the representation of them as one's own original work." It has been noticed that, authors are simply copying scientific data and information from the other published papers, which is unlawful practice in academic fraternity. Therefore, I request to the all authors please adopt the holistic & pragmatic approach to design the manuscript of interest.
eIJPPR will not be responsible for further action on Plagiarism issue. The author will be solely responsible for plagiarism issue.
Authors will have to pay a nominal cost of Rs.1500/-(Rupees Fifteen Hundred only) per paper (Cost towards
processing, maintenance of paper in secured data storage system, databases; to meet various overhead expenses like employees charges etc.). This charge is US$ 50 per paper outside India. The cost to be deposited after receiving the acceptance of the article. There is no processing fee for Invited Articles.
Submission is a representation that the manuscript has not been published previously and is not under consideration
for publication elsewhere. Authors would be required to sign a form (COPYRIGHT FORM) transferring copyright before the manuscript can be published.
Manuscript should be submitted online along with a scanned copy of duly signed copy right form by mailing at
following Email ID: [email protected]
First Decision on your article will be taken once we receive comments from reviewers and this duration will not exceed more than 30 days.
Proofs will be sent to the corresponding author by PDF for final proof reading and appropriate corrections and
should be returned via email within 48 hours of receipt. No additions and revisions are allowed other than the correction of typographical errors.
Papers will normally be published in order of acceptance by the editors, quickly as soon as the corrected electronic
manuscripts are received. The details of the published paper (s) will be communicated to the corresponding author.
No responsibility is assumed by the eIJPPR ( Publisher or its staff or members of the editorial board) for any injury
and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. The respective individual author(s) are responsible for the facts and views expressed in their articles.
Prof. Dr. S. Sharma,
Editor in Chief,
International Journal of Pharmaceutical and Phytopharmacological Research (IJPPR), C/O-613-E, Matru-Ami Apartment, Behind New High school, Joshi Baug, Kalyan (W)-421301, Maharashtra, India.
Email: [email protected]